Bengaluru firm ropes in Israel’s P-Cure to launch network of compact proton therapy centres in India
Source Entity
India Latest News: Top National Headlines Today & Breaking News | The Hindu
Bengaluru-based ARISTION Proton Center has partnered with Israel's P-Cure to invest ₹1,900 crore in a network of compact proton therapy centers across India. The initiative launches with a 660-bed facility in Jakkur, aiming to enhance precision oncology through advanced synchrotron-based technology.
Revolutionizing Precision Oncology in India
The landscape of cancer treatment in India is set for a significant transformation as Bengaluru-based ARISTION Proton Center and Israeli medical technology firm P-Cure announce a strategic partnership. By committing ₹1,900 crore toward a network of compact proton therapy centers, the collaboration aims to address the critical gap in accessible, high-precision radiation therapy for cancer patients across the country.
The Technological Edge of P-Cure
At the heart of this initiative is P-Cure’s proprietary, synchrotron-based proton therapy system. Unlike traditional radiation therapy, which can affect surrounding healthy tissues, proton therapy utilizes a targeted beam of protons to deliver energy directly to the tumor site. The compact nature of these systems allows for easier integration into existing hospital infrastructures, effectively lowering the barrier to entry that has historically hindered the widespread adoption of proton beam technology in India.
Sentient Health City: A New Paradigm of Care
The inaugural project will be established at Sentient Health City in Jakkur, Bengaluru. This 660-bed quaternary campus is designed to function as a flagship facility, integrating artificial intelligence and augmented care solutions into its operational framework. By embedding advanced digital health tools alongside proton therapy, the facility aims to optimize patient outcomes and streamline the delivery of complex oncological treatments.
Broadening Access Beyond Bengaluru
The investment plan extends well beyond the initial Bengaluru site. The partnership intends to establish dedicated proton therapy infrastructure across various metropolitan regions, with Kochi already identified as a key location for future expansion. This geographic diversification is essential for a country of India's scale, ensuring that specialized, non-invasive radiotherapy is not confined to a single urban center but becomes part of a broader national healthcare network.
Implications for Indian Healthcare Infrastructure
The deployment of this technology represents a significant shift toward precision medicine. As cancer incidence rates rise, the demand for non-invasive, highly targeted treatments has grown exponentially. By localizing the infrastructure required for proton therapy, ARISTION and P-Cure are not only reducing the dependence on global medical tourism for such procedures but are also fostering a domestic ecosystem capable of supporting long-term, high-acuity care.
Future Trends and Outlook
Looking ahead, this partnership signals a trend of increased international collaboration in Indian healthcare. The integration of AI-driven care protocols with advanced hardware sets a new standard for hospital design. If successful, this model of 'compact' infrastructure could become the blueprint for future oncology centers, potentially accelerating the transition toward personalized, data-backed treatment pathways in the Indian medical sector.
Verification Required?